-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2024.
- BioXcel Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2024 was -22.1 USD/shares, a 76.2% increase year-over-year.
- BioXcel Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2024 was -23.5 USD/shares, a 76.1% increase year-over-year.
- BioXcel Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -23.5 USD/shares, a 76.1% increase from 2023.
- BioXcel Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -98.3 USD/shares, a 1561% decline from 2022.
- BioXcel Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -5.92 USD/shares, a 46.2% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)